Here are the 42 stocks moving the market today

Momenta Pharmaceuticals, Inc. MNTA shares rose 68% to $52.00 in pre-market trading after Johnson & Johnson announced plans to acquire Momenta Pharmaceuticals for $6.5 billion in cash.

  • Hudson Ltd. HUD 0.29% shares rose 48.2% to $7.60 in pre-market trading after the company reported proposed acquisition of all remaining equity interests in the company for $7.70 per share in cash by Dufry AG Group, Hudson’s controlling shareholder.
  • 9 Meters Biopharma, Inc. NMTR rose 40% to $0.9101 in pre-market trading following the company’s form 4 filing indicating an insider buy of 100,000 shares. 9 Meters Biopharma shares jumped around 17% on Tuesday after Brookline Capital initiated coverage on the company’s stock with a Buy rating and announced a $5 price target.
  • LightInTheBox Holding Co., Ltd. LITB 0.88% rose 32% to $3.73 in pre-market trading after the company swung to a profit in the second quarter. The company said it expects Q3 sales of $95 million to $110 million.
  • Blonder Tongue Laboratories, Inc. BDR shares rose 23.8% to $0.94 in pre-market trading after dropping over 4% on Tuesday. Blonder Tongue Laboratories, earlier during the month, reported results for the second quarter.
  • Teligent, Inc. TLGT rose 19.3% to $2.54 in pre-market trading.
  • Four Seasons Education (Cayman) Inc. FEDU 0.85% rose 15.2% to $1.36 in pre-market trading. Four Seasons Education is expected to release quarterly results on August 20.
  • Unum Therapeutics Inc. UMRX shares rose 10.7% to $3.00 in pre-market trading. Unum Therapeutics released Q2 results last week.
  • MOGU Inc. MOGU 0.74% rose 10.7% to $3.01 in pre-market trading after jumping 24% on Tuesday.
  • Flux Power Holdings, Inc. FLUX rose 10.7% to $4.65 in pre-market trading after dropping 17% on Tuesday Flux Power reported pricing of $10.8 million public offering last week.
  • Verona Pharma plc VRNA rose 10.4% to $9.05 in pre-market trading after the company initiated multiple dose part of Phase 2 clinical trial with pMDI formulation of ensifentrine in patients with chronic obstructive pulmonary disease.
  • Accelerate Diagnostics, Inc. AXDX rose 9.8% to $16.30 in pre-market trading after the company announced the FDA issued Emergency Use Authorization for its BioCheck Covid-19 antibody testing system.
  • CytomX Therapeutics, Inc. CTMX rose 8.5% to $7.79 in pre-market trading.
  • OneSmart International Education Group Limited ONE 0.09% rose 8.1% to $5.86 in pre-market trading. OneSmart shares jumped over 30% on Tues after reporting Q3 results.
  • BioLineRx Ltd. BLRX rose 8.1% to $2.28 in pre-market trading after the company announced it has achieved its enrollment target in the phase 3 GENESIS trial for planned interim analysis.
  • Eastman Kodak Company KODK 0.06% rose 7.9% to $8.64 in pre-market trading after rising around 5% on Tuesday.
  • Energous Corporation WATT shares rose 7.9% to $4.25 in pre-market trading after climbing 18% on Tuesday. Energous, last week, introduced EN7410M module, a new wireless charging transmitter module.
  • Precipio, Inc. PRPO rose 7.3% to $2.76 in pre-market trading after declining around 21% on Tuesday. Precipio released Q2 results last week.
  • Pulmatrix, Inc. PULM rose 6.4% to $1.33 in pre-market trading. Pulmatrix reported Q2 results earlier during the month.
  • Target Corporation TGT rose 5.7% to $144.70 in pre-market trading after reporting upbeat quarterly results. The company also reported Q2 comparable sales grew 24.3% and digital comparable sales grew 195%.
  • Golden Ocean Group Limited GOGL rose 5.2% to $4.50 in pre-market trading. On Tuesday, Golden Ocean reported a Q2 loss of $0.29 per share.
  • Abraxas Petroleum Corporation AXAS rose 5% to $0.21 in pre-market trading. Abraxas Petroleum shares jumped around 16% on Tuesday after the company’s board determined to renew the strategic alternatives review announced last October
Share: